Correction to : GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia
| Errataetall: |
ErratumFor: Infect Dis Ther. 2022 Apr;11(2):757-770. - PMID 35118580 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Infectious diseases and therapy - 11(2022), 3 vom: 18. Juni, Seite 1313 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
De Ryck, Iris [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 24.05.2022 published: Print ErratumFor: Infect Dis Ther. 2022 Apr;11(2):757-770. - PMID 35118580 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s40121-022-00634-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM339649917 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM339649917 | ||
| 003 | DE-627 | ||
| 005 | 20231226003354.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40121-022-00634-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1132.xml |
| 035 | |a (DE-627)NLM339649917 | ||
| 035 | |a (NLM)35435576 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a De Ryck, Iris |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to |b GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.05.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumFor: Infect Dis Ther. 2022 Apr;11(2):757-770. - PMID 35118580 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Sarakinou, Eleanna |e verfasserin |4 aut | |
| 700 | 1 | |a Nakakana, Usman |e verfasserin |4 aut | |
| 700 | 1 | |a Cilio, Giulia Luna |e verfasserin |4 aut | |
| 700 | 1 | |a Ndiaye, Augustin |e verfasserin |4 aut | |
| 700 | 1 | |a Vella, Venanzio |e verfasserin |4 aut | |
| 700 | 1 | |a Auerbach, Joachim |e verfasserin |4 aut | |
| 700 | 1 | |a Granada, Juan-Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Conti, Valentino |e verfasserin |4 aut | |
| 700 | 1 | |a Podda, Audino |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infectious diseases and therapy |d 2012 |g 11(2022), 3 vom: 18. Juni, Seite 1313 |w (DE-627)NLM240483693 |x 2193-8229 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2022 |g number:3 |g day:18 |g month:06 |g pages:1313 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40121-022-00634-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2022 |e 3 |b 18 |c 06 |h 1313 | ||